Overview Vinorelbine for Recurrent ALCL-2017 Status: Recruiting Trial end date: 2025-09-01 Target enrollment: Participant gender: Summary The purpose of this study is to assess the efficiency and safety of vinorelbine in the treatment of relapsed / advanced ALCL in children and adolescents. Phase: Phase 2 Details Lead Sponsor: Children's Cancer Group, ChinaTreatments: VinblastineVinorelbine